Diet Modification Clinical Trial
Official title:
Gastrointestinal Assessment of Three Novel Resistant Starch Type IV
The rates of chronic diseases like obesity, diabetes, and heart disease are rising across the
world. This is especially true in industrialized countries like Canada and the USA. Even
though there are many possible causes for these increases. One prominent cause is our refined
diet, which greatly lacks dietary fiber. This 'fiber gap' between the amount of fiber
actually eaten and the amount that should be eaten is likely promoting these diseases.
It is known that a high fiber diet can benefit health and the health of the gut bacteria. It
is also know that these gut microbes can help cause and prevent diseases. When fiber is
eaten, it gets broken down not by us, but by our gut microbes. During this process
by-products called short-chain fatty acids (SCFA) are made. These SCFA have been shown to
promote health. Therefore, it is thought that fiber changes the gut microbes to produce more
SCFA, which may improve overall health.
In order to aid our microbes and improve our health we need to find ways to reduce this
'fiber gap'. One possibility is to add fiber to our refined diet. To do so we must first
learn how different fibers perform in our gut. This includes how our gut tolerates increasing
amounts of fiber, and how our microbes respond. The purpose of this study is to learn how
different types of resistant starch perform in our gut, including gastrointestinal tolerance.
By doing so we will determine the ideal dose and type of these fibers to use in future
studies.
The investigators propose a 4 week gastrointestinal (GI) assessment study to determine both
the ideal dose and type of resistant starch to use in future studies. The following specific
aims are offered:
AIM 1: GI Tolerance. Preform a randomized, placebo-controlled, double-blind,
parallel-four-arm human intervention study to assess the GI tolerance of 3 novel resistant
starch type IV (RS4) at dose up to 50 g per day.
Interested participants will be asked to attend a screening visit at Human Nutrition Research
Unit, where lifestyle and anthropometric information will be collected to determine
eligibility. Eligible participants (N = 40) will be stratified based on gender and randomly
assigned to 1 of 4 groups, where they will be asked to supplement their diet for 4 weeks with
either a RS4 (experimental arms) or a digestible starch (control arm). The weight of total
starch (digestible plus RS) provided in each experimental arm will be dependent on the purity
of the individual RS4 products. Subjects will supplement their diet with 10 g, 20 g, 35 g and
50 g of total dietary fiber (as RS) daily over the course of weeks 1, 2, 3 and 4,
respectively. The amount of digestible starch provided in the control arm will be equal to
the mean amount of total starch provided across the 3 experimental arms. All starch products
will be provided in powder form.
Methodologies previously described by Maki et al. will be employed to evaluate the overall GI
tolerance of the RS4 products by assessing changes in GI symptom, bowel movement frequency,
and bowel movement consistency, and by comparing these changes to those changes observed in
the control arm (digestible starch - Maki et al., Int J Food Sci Nutr, 2013). Participants
will keep a daily study journal, which included a bowel habits questionnaire, over the course
of the 4 week study, and they will also complete weekly GI tolerance and satiety
questionnaires during their weekly study visits. Participants will also be asked to complete
two 24-h recalls, both prior to starting the dietary intervention and during week 4. All 24-h
recalls will be completed online through the Canadian Automated Self-Administered 24h (ASA24)
recall system.
AIM 2: Evaluate prebiotic and dose dependent effect on the microbiome. Evaluate the effect of
the 3 distinct RS4 types on gut microbiota composition and structure in a dose dependent
manner.
Fecal samples will be collected at baseline and at the end of each intervention week (weeks
1-4). Fecal samples will be used to both characterize the fecal microbial community via 16S
ribosomal RNA next-generation sequencing, and to quantify fecal short-chain fatty acid
concentrations via gas chromatography. Short-term characterization of the fecal microbiome
will provide a systematic assessment of the individualized response between 3 structurally
distinct types of RS4, while further allowing an intricate assessment of the prebiotic dose
effect upon significantly increasing the dose of RS towards 50 g per day. This analysis will
provide critical information on how distinct types of RS4 shape the gut microbiome in humans,
and which dose is necessary to achieve such effects.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03700736 -
The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups
|
N/A | |
Terminated |
NCT03517111 -
The Impact of a Parenting Intervention on Latino Youth Health Behaviors
|
N/A | |
Completed |
NCT03675360 -
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
|
N/A | |
Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
Recruiting |
NCT03682640 -
Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes
|
Phase 2 | |
Terminated |
NCT02047136 -
Dietary Treatment for Chronic Urticaria
|
N/A | |
Active, not recruiting |
NCT05544461 -
Piloting a Web-based Personalised Nutrition App (eNutri) With UK University Students
|
N/A | |
Completed |
NCT03290118 -
The Efficacy of Front-of-package Labelling Schemes: an Experimental Study
|
N/A | |
Suspended |
NCT04124016 -
Metabotypes in the Urinary Excretion of Flavan-3-ol Metabolites: "Metanols"
|
N/A | |
Completed |
NCT03457688 -
Effect of Prebiotic Fructans to Reduce Number of Febrile Infections in Children
|
N/A | |
Completed |
NCT03241355 -
Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children
|
N/A | |
Recruiting |
NCT04616482 -
Therapeutic Nutrition With Technology in Primary Care
|
||
Recruiting |
NCT04401605 -
Fermented Food-Supplemented Diet in Ulcerative Colitis
|
N/A | |
Completed |
NCT03697317 -
Televideo Exercise and Nutrition Program for Kidney Transplant Recipients
|
N/A | |
Completed |
NCT03748056 -
Targeted Food Incentives to Improve Diet Quality and Health Among Adults
|
N/A | |
Not yet recruiting |
NCT03657316 -
Impact of School Based Education Program
|
N/A | |
Completed |
NCT03934476 -
The Effects of Lowering Dietary Carbohydrates on Health, Exercise Performance and Wellbeing-related Outcomes
|
N/A | |
Completed |
NCT03129581 -
Metabolic Impact of Time Restricted Feeding
|
N/A | |
Completed |
NCT03716479 -
Gum Acacia and Blood Glucose
|
N/A | |
Recruiting |
NCT03977558 -
Health Effect of Canola Oil Consumption in Shift Workers
|
N/A |